Atenolol and Zicam drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Atenolol and Zicam. Common interactions include headache among females and anosmia among males.

The phase IV clinical study analyzes what interactions people who take Atenolol and Zicam have. It is created by eHealthMe based on reports of 54 people who take Atenolol and Zicam from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 14, 2023

54 people who take Atenolol and Zicam together, and have interactions are studied.

What is Atenolol?

Atenolol has active ingredients of atenolol. It is often used in high blood pressure. eHealthMe is studying from 172,878 Atenolol users for its effectiveness, alternative drugs and more.

What is Zicam?

Zicam has active ingredients of zinc gluconate. It is often used in herpes labialis (oral herpes simplex). eHealthMe is studying from 5,200 Zicam users for its effectiveness, alternative drugs and more.

Number of Atenolol and Zicam reports submitted per year:

Common Atenolol and Zicam drug interactions by gender *:

female:

Headache
Nausea
Psoriasis
Wound
Back pain
Atrial fibrillation
Burning sensation
Deafness
Disease recurrence
Dysgeusia

male:

Anosmia
Ageusia
Burning sensation
Heart rate increased
Hypogeusia
Palpitations

Common Atenolol and Zicam drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Anosmia

30-39:

Disease recurrence

40-49:

Anosmia
Ageusia
Burning sensation
Chronic kidney disease
Renal failure

50-59:

Anosmia
Ageusia
Deafness
Headache
Insomnia
Pre-existing condition improved
Therapeutic response unexpected
Tinnitus

60+:

Ageusia
Anosmia
Palpitations
Swollen tongue
Hypoaesthesia oral
Heart rate increased
Atrial fibrillation
Dysgeusia
Headache
Hypogeusia

Common conditions people have *:

Nasopharyngitis (inflammation of the nasopharynx): 16 people, 29.63%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 7.41%
Urinary Tract Infection: 3 people, 5.56%
Stress And Anxiety: 3 people, 5.56%
Sleep Disorder: 3 people, 5.56%
Pain: 3 people, 5.56%
Osteopenia (a condition where bone mineral density is lower than normal): 3 people, 5.56%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 5.56%
Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 5.56%
Gout (uric acid crystals building up in the body): 3 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Atenolol and Zicam?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Atenolol (172,878 reports)
Zicam (5,200 reports)